ÂÜÀòÂÒÂ×

Katherine Melville is a seasoned professional in the biotechnology and sequencing fields, currently serving as a Regional Sequencing Specialist at Oxford Nanopore Technologies since March 2017. Katherine has also held roles as Clinical Market Development Manager, Clinical Market Development Associate, and Nanopore Account Specialist within the same organization. Prior to this, Katherine gained experience at Illumina as an Oncology Market Development Associate through the competitive iAspire program. Earlier roles include an Immunotherapy Research Technician at Fred Hutch, where responsibilities involved applying immunology-based assays in clinical trials, and an Undergraduate Research Assistant at the University of California San Diego, focusing on induced pluripotent stem cells and cardiovascular disease. Katherine holds a Master's Degree in Biotechnology from Columbia University and a Bachelor of Science in Human Biology from UC San Diego.